Sanofi describes novel glucagon receptor ligands for diabetes drug development Nov. 6, 2017 No Comments
KSQ Therapeutics secures USD 76 million to support CRISPRomics-powered drug discovery Oct. 3, 2017 No Comments
Novartis and UC Berkeley form alliance to unlock undruggable disease targets Sep. 28, 2017 No Comments
G3 Pharmaceuticals starts research and development program to pursue novel galectin-3 inhibitors Sep. 19, 2017 No Comments
RSS